The document discusses open data and open access in biomedical research from a data and text mining perspective. It notes the large amount of biomedical data and text available, challenges of understanding what is known, and importance of public databases and open licensing to support open science. It also discusses using data mining of clinical records from millions of patients to discover new adverse drug reactions and safety issues at a scale not possible from traditional trials.